Assessment of (S)-4-(iodobenzyl)-?-glutamate as a Novel xCT-Targeted Radiotheranostic for Non-Small Cell Lung Cancer (2026)
Attributed to:
A multi-user radiochemical synthesis facility for molecular imaging research
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract